Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Pesonen (Stockholm, Sweden), J. Gao (Stockholm, Sweden), D. Kalafatis (Stockholm, Sweden), L. Carlson (Stockholm, Sweden), M. Myllärniemi (Helsinki, Finland), G. Ferrara (Stockholm, Sweden), M. Sköld (Stockholm, Sweden). Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis. 2200

Member's Comments

No comment yet.

Related content which might interest you: Forced vital capacity decreases rapidly in patients with idiopathic upper lobe-dominant pulmonary fibrosis Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity? Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Static lung compliance and DLCO often demonstrate parenchymal involvement in sarcoidosis despite a normal total lung capacity Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (2) 1702593; 10.1183/13993003.02593-2017 Year: 2018 Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) – modelling the myth Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO) Source: Annual Congress 2008 - Exercise: system responses Year: 2008 Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 35: 830-836 Year: 2010 Static lung compliance (Cst) and diffusion lung capacity (DLCO) as markers of lung function impairment in sarcoid patients with normal lung volumes Source: Eur Respir J 2003; 22: Suppl. 45, 278s Year: 2003 Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis Source: Eur Respir J 2012; 40: 61-66 Year: 2012 Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity Source: Eur Respir J 2008; 31: 391-395 Year: 2008 Lung diffusion measurement: effects of alveolar volume changes on diffusing capacity and implications in restrictive lung disease Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases Year: 2004 Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis Source: Eur Respir J 2010; 36: 1315-1322 Year: 2010 Lung volumes, diffusing capacity and static lung compliance in patients with UIP pattern of IPF Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006 Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes Source: Eur Respir Rev 2012; 21: 161-167 Year: 2012 Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD Source: Eur Respir J 2008; 32: 1275-1282 Year: 2008 Lung function measurement in respiratory diseases: mechanisms Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease Year: 2006 Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018 Forced oscillation technique in patients with systemic sclerosis comparison with diffusing capacity Source: Eur Respir J 2001; 18: Suppl. 33, 204s Year: 2001